mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |